Future research should focus on elucidating the molecular mechanisms of ARK2N in muscle adaptation, validating its effects across diverse populations, and investigating its potential as a therapeutic target for sarcopenia and other muscle-related conditions. Here, ARK2N is linked to sarcopenia.